Alprazolam (Xanax)

Drug Class: Benzodiazepine (short-acting)

Brand Name: Xanax, Xanax XR (extended-release), generic Alprazolam

Mechanism of Action:

Alprazolam binds to benzodiazepine receptors (GABA-A receptors) in the central nervous system. This binding enhances the affinity of gamma-aminobutyric acid (GABA) for its receptor, which increases chloride channel opening frequency. The resulting hyperpolarization of neurons produces a calming effect on the brain and nervous system.

Indications:

• Generalized Anxiety Disorder (GAD)

• Panic Disorder with or without agoraphobia

• Short-term relief of anxiety symptoms

• Anxiety associated with depression (off-label in some contexts)

Available Formulations:

• Immediate-release tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg

• Extended-release tablets (Xanax XR): 0.5 mg, 1 mg, 2 mg, 3 mg

• Orally disintegrating tablets (ODT)

• Oral solution (concentrate)

Typical Dosage (Adults):

• Generalized Anxiety Disorder: 0.25 mg to 0.5 mg three times daily, maximum 4 mg per day

• Panic Disorder: Starting 0.5 mg to 1 mg once daily (XR) or 0.5 mg three times daily (IR), titrated up to 5-10 mg per day in some cases

• Elderly or debilitated patients: Starting 0.25 mg two to three times daily

Duration of Action:

• Immediate-release: Onset 30-60 minutes, duration 4-6 hours

• Extended-release: Onset similar, duration up to 12 hours

Contraindications:

• Hypersensitivity to alprazolam or any benzodiazepine

• Narrow-angle glaucoma

• Concurrent use with ketoconazole or itraconazole

• Concurrent use with strong CYP3A4 inhibitors

• Myasthenia gravis

• Severe respiratory insufficiency

• Sleep apnea syndrome

• Severe hepatic impairment

Boxed Warnings (FDA):

1. Concomitant use with opioids: May result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for patients with no alternative treatment options.

2. Abuse, misuse, and addiction: Benzodiazepines including Xanax can lead to abuse, misuse, addiction, and overdose.

3. Dependence and withdrawal: Physical dependence can occur. Abrupt discontinuation or rapid dose reduction can cause acute withdrawal reactions, including seizures and death.

4. Neonatal sedation and withdrawal syndrome: Use during pregnancy, especially in the third trimester, can cause neonatal sedation and withdrawal symptoms.

Common Side Effects:

• Drowsiness and sedation (most common)

• Fatigue

• Dizziness

• Lightheadedness

• Dry mouth

• Increased salivation

• Headache

• Blurred vision

• Constipation or diarrhea

• Nausea or vomiting

• Changes in appetite and weight

• Difficulty with coordination (ataxia)

• Slurred speech (dysarthria)

Serious Side Effects:

• Respiratory depression (especially with opioids or alcohol)

• Severe hypotension (low blood pressure)

• Memory impairment (anterograde amnesia)

• Paradoxical reactions (agitation, aggression, hostility, rage, hallucinations) – more common in children and elderly

• Suicidal ideation (in patients with depression)

• Seizures (during withdrawal)

• Prolonged QT interval (rare)

Tolerance, Dependence, and Withdrawal:

• Tolerance: Reduced response to the same dose over time, requiring dose escalation for same effect.

• Physical dependence: Adaptation of the body to the presence of the drug. Abrupt cessation causes withdrawal symptoms.

• Psychological dependence (addiction): Compulsive use despite harm.

Withdrawal Symptoms (can occur within 24-48 hours of last dose):

• Rebound anxiety (return of anxiety symptoms worse than before treatment)

• Insomnia

• Irritability and agitation

• Tremors

• Sweating

• Tachycardia (rapid heart rate)

• Panic attacks

• Confusion

• Seizures (grand mal seizures can occur)

• Psychosis (rare)

Pregnancy:

• FDA Pregnancy Category D (positive evidence of human fetal risk)

• Third trimester use: Risk of neonatal sedation, hypotonia (floppy baby syndrome), and withdrawal syndrome

• Breastfeeding: Alprazolam is excreted in breast milk. Use not recommended.

Drug Interactions (Major):

• Opioids (oxycodone, hydrocodone, morphine, fentanyl): Additive CNS depression, profound sedation, respiratory depression, coma, death

• Alcohol: Dangerous additive CNS depression, increased risk of overdose and death

• Other benzodiazepines and sedatives: Additive effects

• Antihistamines (diphenhydramine, hydroxyzine): Increased sedation

• Antipsychotics, antidepressants, anticonvulsants: Additive CNS effects

• CYP3A4 inhibitors (ketoconazole, itraconazole, fluconazole, erythromycin, clarithromycin, grapefruit juice): Increased alprazolam levels, prolonged effects

• CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John’s wort): Decreased alprazolam levels, reduced efficacy

• Digoxin: Increased risk of digoxin toxicity

• Oral contraceptives: May reduce alprazolam clearance

Overdose Signs:

• Severe drowsiness and confusion

• Slurred speech

• Impaired coordination (ataxia)

• Hypotension (low blood pressure)

• Respiratory depression (slow or shallow breathing)

• Coma

Overdose Treatment:

• Activated charcoal if within 1-2 hours of ingestion

• Flumazenil (benzodiazepine antagonist) – used cautiously due to risk of seizures, especially in chronic users

• Respiratory support and monitoring

• Symptomatic and supportive care

Note: Overdose with benzodiazepines alone rarely causes death, but combined with alcohol or opioids is frequently fatal.

Storage:

• Store at room temperature (20-25°C / 68-77°F)

• Protect from light and moisture

• Keep in a secure, locked cabinet out of reach of children

• Avoid storage in bathrooms

Disposal:

• Use drug take-back programs where available

• Do not flush unless specifically instructed by FDA or local guidelines

• Do not dispose in household trash without proper mixing with undesirable substances (e.g., coffee grounds, cat litter)

Abuse Potential:

• Schedule IV controlled substance – lower abuse potential than Schedule II opioids, but significant nonetheless

• Commonly abused for its sedative, calming, and euphoric effects

• Often combined with opioids or alcohol – dangerous and potentially fatal

• Withdrawal seizures can occur with abrupt discontinuation after regular use

Safe Use Message for Education:

Alprazolam should be used exactly as prescribed, for the shortest duration necessary. It is not for long-term daily use unless other treatments have failed. Do not share with others. Do not drink alcohol. Do not take with opioids unless specifically directed by a physician. Do not stop abruptly without medical supervision.